Previous Article | Next Article 
Infection and Immunity, September 1999, p. 4700-4707, Vol. 67, No. 9
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Preliminary Characterization of a
Mycobacterium abscessus Mutant in Human and Murine Models
of Infection
Thomas F.
Byrd1,2,* and
C. Rick
Lyons2
Department of Medicine, Albuquerque Veterans
Affairs Medical Center,1 and The
University of New Mexico School of
Medicine,2 Albuquerque, New Mexico 87108
Received 9 March 1999/Returned for modification 7 April
1999/Accepted 18 June 1999
 |
ABSTRACT |
The ability to persist in the host after the establishment of
infection is an important virulence determinant for mycobacteria. Mycobacterium abscessus is a rapidly growing mycobacterial
species which causes a variety of clinical syndromes in humans. We have obtained a rough, wild-type human clinical isolate of M. abscessus (M. abscessus-R) and a smooth, attenuated mutant
(M. abscessus-S) which spontaneously dissociated from the
clinical isolate. We have found that M. abscessus-R is able
to persist and multiply in a murine pulmonary infection model in
contrast to M. abscessus-S, which is rapidly cleared. To
understand the basis for this difference, we characterized the behavior
of these variants in human tissue culture models of infection. M. abscessus-R is able to persist and multiply in human monocytes,
while M. abscessus-S is deficient in this ability. Both of
these variants are phagocytized by human monocytes. M. abscessus-R resides in a phagosome typical for pathogenic mycobacteria with a tightly adherent phagosomal membrane. In contrast, M. abscessus-S resides in a "loose" phagosome with the
phagosomal membrane separated from the bacterial cell wall. Both
M. abscessus variants also have distinctive growth patterns
in a recently described fibroblast-mycobacterium microcolony assay,
with M. abscessus-R exhibiting growth characteristics
similar to those previously reported for virulent M. tuberculosis and M. abscessus-S exhibiting growth
characteristics similar to those previously reported for avirulent
M. tuberculosis. In both the monocyte infection assay and
the murine pulmonary infection model, numerous infected mononuclear phagocyte aggregates develop at sites of M. abscessus-R
infection, but are absent with M. abscessus-S infection. We
conclude that a mutation has occurred in the M. abscessus-S
variant which has altered the ability of this organism to persist and
multiply in host cells and that this may be related to the phenotypic
changes we have observed in our tissue culture models of infection.
 |
INTRODUCTION |
Mycobacterial diseases are
significant causes of morbidity and mortality. Non-tuberculous
mycobacteria are being increasingly identified in clinical specimens
(31). Mycobacterium abscessus is a rapidly
growing mycobacterial species which causes a variety of clinical
syndromes in humans (31), including skin and soft tissue
infection, disseminated infection, lymphadenitis, postoperative catheter-related infection, and bone and joint infection. M. abscessus was formerly considered to be a subspecies of
Mycobacterium chelonae (M. chelonae subsp.
abscessus), but on the basis of DNA homology studies it has
been shown to be genetically distinct and has thus been elevated to a
separate species status (29). Its increasing clinical
importance is highlighted by the fact that its has recently been
described to cause a well-characterized chronic bronchopulmonary infection similar to that caused by Mycobacterium avium
(15, 25).
In addition to their significance as human pathogens, nontuberculous
mycobacteria have been used as models to study the pathogenesis of
infection caused by mycobacteria in general. For example,
Mycobacterium marinum infection of the leopard frog
(Rana pipiens) has been used as a model of mycobacterial
pathogenesis because of its similarity to tuberculosis. In this model,
M. marinum causes a nonlethal chronic granulomatous disease
in immunocompetent frogs. Immunosuppression associated with
hydrocortisone treatment results in acute fulminant, lethal disease
(26). In addition, M. marinum infection of
macrophages has been used as a model to study intracellular trafficking
of mycobacteria. In one study, M. marinum localized to a
similar intracellular vacuole as M. tuberculosis
(2). Finally, because of similarities of M. tuberculosis and Mycobacterium leprae, M. marinum has been used to study the oxidative stress response of pathogenic mycobacteria (24).
To aid in our study of mycobacterial pathogenesis, we have obtained a
rough, wild-type isolate of M. abscessus (M. abscessus-R) and a smooth, attenuated mutant (M. abscessus-S) which spontaneously dissociated from a single human
clinical isolate. In this study we show that M. abscessus-R
is able to persist in a murine pulmonary model of infection in contrast
to M. abscessus-S, which is not. As a first step toward
characterizing the basis for mycobacterial persistence, we have
identified phenotypic differences between these variants in human
tissue culture models of infection.
 |
MATERIALS AND METHODS |
Mycobacterial strains.
M. abscessus variants were
obtained from Blaine Beaman at The University of California, Davis.
M. abscessus-R was isolated in pure culture from an ileal
granuloma in a patient with Crohn's disease. This form induced
granuloma formation in both the ileum and colon of goats
(2a). M. abscessus-S was a spontaneous mutant of
the rough colony strain isolated in vitro (2a). To support the observation that M. abscessus-R and M. abscessus-S are derived from the same isolate, additional studies
were performed. Both variants have essentially identical elution
patterns on high-pressure liquid chromatography (HPLC) identifying them
as M. abscessus, and other M. abscessus strains
show greater differences in their elution patterns when compared to
these two variants, supporting their close identity (11a).
In addition to forming nonpigmented colonies and having a rapid growth
rate, biochemical analysis showed both these variants to be M. abscessus (nitrate reduction negative, positive for growth in 5%
NaCl, iron uptake negative, citrate negative, inositol negative, and
mannitol negative). Restriction enzyme analysis was performed after PCR
amplification of a portion of the gene encoding for the 65-kDa heat
shock protein. Using the restriction endonucleases BstEII
and HaeIII, both isolates were found to be identical to the
M. abscessus control strain. Finally, random amplified
polymorphism detection was performed on both variants. In this
technique, short primers with arbitrary sequences and nonstringent PCR
conditions are used to generate variable-length fragments which vary
according to the sequence of the isolates being tested. Identical
patterns for M. abscessus-R and M. abscessus-S
were obtained by using two separate reactions with different random
primers supporting the close genetic identity of these variants
(13a).
These variants have remained stable through 10 passages in bacterial
culture media. Furthermore, in eight separate infection experiments in
mice, each using both variants, we have not observed a change in colony
morphology of either M. abscessus-R or M. abscessus-S recovered from the lung or spleen, further attesting
to phenotypic stability of these variants.
Bacterial culture media.
Middlebrook 7H9 broth (Difco,
Detroit, Mich.) was used for the dilution of culture supernates and
lysates prior to plating for CFU. Middlebrook 7H11 agar (Difco) plates
(100- by 15-mm bacteriologic petri dishes) were used for plating CFU
from infected monolayers and supernates.
Mice.
Female BALB/c and SCID mice were obtained from The
Jackson Laboratory, Bar Harbor, Maine. Animals were maintained in a
specific-pathogen-free environment. The animal colonies were screened
regularly for the presence of murine pathogens.
Murine pulmonary infection assay.
M. abscessus used in
these experiments was the second passage of bacteria originally
received from B. Beaman. M. abscessus was grown in 100 ml of
7H9 broth, harvested by centrifugation, and resuspended in
phosphate-buffered saline (PBS)-Tween. Bacteria were then sonicated in
an ultrasonic cell disrupter (Microson XL; Heat Systems, Farmingdale,
N.Y.) to disperse organisms, and any remaining clumps allowed to settle
for 15 min. The supernatant was then removed, aliquoted, and flash
frozen. A new aliquot was used for each experiment. Prior to
inoculation into animals, M. abscessus suspensions were
sonicated for 30 s to ensure a uniform bacterial suspension.
Mice were anesthetized by using an intraperitoneal injection of
Avertin. An incision was made over the trachea of anesthetized, restrained mice. With a 30-gauge bent needle and syringe, 50 µl of
M. abscessus-R or M. abscessus-S bacterial
suspensions containing 104 CFU in nonpyrogenic saline was
injected into the trachea, and the incision was closed with Super Glue.
At various time points after infection (days 7, 14, 21, and 28), mice
were sacrificed and the lungs and spleens removed and placed in 3.0 ml
of PBS. The organs were homogenized, and dilutions were plated in
triplicate by the microdrop technique. Briefly, 25 µl of the dilution
was placed as a drop on Middlebrook 7H11 agar. The drops were then allowed to absorb into the agar before incubation in a humidified incubator at 37°C in 10% CO2 for 2 to 4 days. After
incubation the microcolonies are counted by using a stereomicroscope.
In addition to CFU, histopathologic sections were obtained and stained with hematoxylin and eosin in order to examine the histology of M. abscessus-infected lungs.
Human cells.
Human blood mononuclear cells were obtained
from buffy coats purchased through United Blood Services (Albuquerque,
N.M.). The blood mononuclear cell fraction was obtained by
centrifugation over a Ficoll-sodium diatrizoate solution (Pharmacia
Fine Chemicals, Piscataway, N.J.), and monocytes were plated as
previously described (9).
Tissue culture media.
Iscove's modified Dulbecco's medium
(Gibco Laboratories, Grand Island, N.Y.) was used in tissue culture experiments.
Serum.
Venous blood was obtained from healthy adult
volunteers with no history of tuberculosis or a positive tuberculin
skin test. Serum was separated and stored at
70°C. Autologous or
heterologous serum was used in experiments.
Assay for growth of M. abscessus in human
monocytes.
Human monocytes adherent to Linbro tissue culture wells
in Iscove's medium-1% normal human serum (NHS) were incubated for 24 h in 5% CO2-95% air at 37°C. Frozen bacterial
stocks of the M. abscessus variants which had been sonicated
and preopsonized in normal human serum as previously described for
M. tuberculosis (9) were used to prepare
inoculating suspensions of bacteria for use in each tissue culture
experiment. Bacteria frozen were the second passage of M. abscessus originally received from B. Beaman. Monolayers were
infected with 2.5 × 105 M. abscessus-R or
M. abscessus-S for 6 h and then washed three times with
media. A time zero count was plated, and then amikacin at 30 µg/ml
was added to the tissue culture medium to kill any remaining
extracellular bacteria. After 48 h the monolayers were washed
three times with medium, and amikacin not re-added. Subsequently, at
24-h intervals, the monolayers were washed twice with medium to prevent
bacterial overgrowth in the medium by extracellular bacteria. Platings
for supernate and lysate CFU were performed at 48, 72, and 120 h
as previously described for M. tuberculosis (9).
Similar results were obtained either by vortexing the bacteria in
Eppendorf tubes containing three glass beads or by sonicating the
bacteria with an ultrasonic cell disrupter prior to plating. In some
experiments, the growth of the M. abscessus variants was
assessed by a radiometric method that measured microbial metabolism
(18). Infected M. abscessus-R and M. abscessus-S monocyte lysates in 0.5-ml aliquots were inoculated
into BACTEC 12B bottles containing 7H12 Middlebrook broth (Becton
Dickinson, Sparks, MD) and the growth index determined daily by using a
BACTEC 460 instrument (Becton Dickinson, Sparks, Md.). In all
experiments, monocyte viability was also analyzed in replicate infected
wells by trypan blue exclusion as previously described (9)
to ensure that the two variants did not have a differential effect on
monocyte viability independent of bacterial growth.
Fibroblast-mycobacterium microcolony assay.
Fibroblast
monolayers were prepared as previously described (10). After
fibroblast monolayers had become confluent (3 to 6 days), the wells
were washed three times with Iscove's medium, and Iscove's medium
alone was re-added. After a 24-h equilibration period, the wells were
inoculated with various concentrations of M. abscessus-R or
M. abscessus-S prepared from stock cultures as described
above. After a 1-h incubation at 37°C in 5% CO2-95% air, the monolayers were washed three times with 37°C Iscove's medium, and 3.0 ml of 50 to 52°C Iscove's medium-agar (Difco) overlay was added to each well. After the overlay was hardened at room
temperature, the plates were incubated in a humidified incubator at
37°C in 5% CO2-95% air. Fibroblast monolayers were shown to be viable, as assessed by the addition of a 0.5-ml agar overlay containing neutral red, which penetrated the agar and concentrated in the nuclei of viable cells. At various time intervals, microcolonies were visually inspected for microcolony morphology and
photographed with a tissue culture microscope (Nikon, Melville, N.Y.).
Microcolonies were fixed by adding 3.0 ml of 80% PBS-20% formaldehyde to each well for 24 h, followed by removal of the agar-medium overlay. Ziehl-Neelsen staining (30) was
performed, without methylene blue counterstaining, by flooding the
bottom of the wells with carbon fuchsin for 5 min, followed by removal and decolorization with acid alcohol. As a final step, the wells were
washed several times washes with double-distilled water. Precise
quantitation of microcolony morphology was achieved by photographing
the stained microcolonies at ×20 by using a tissue culture microscope
(Nikon). By using 4-in.-by-6-in. black-and-white prints, the diameter
of the individual microcolonies, measured in the longest dimension, was
measured and corrected to the actual size in millimeters. Mean
microcolony diameters were obtained for M. abscessus-R and
M. abscessus-S.
Electron microscopy.
Human monocytes adherent to 60-mm
tissue culture-treated dishes (Costar, Cambridge, Mass.) in Iscove's
medium-1% NHS were incubated for 24 h in 5%
CO2-95% air at 37°C. Monocytes were then infected with
106 M. abscessus-R or M. abscessus-S
for 1 h. The monolayers were then washed three times with 37°C
Iscove's media and incubated for an additional 30 min in 5%
CO2-95% air at 37°C to allow for internalization of the
bacteria. The monolayers were then fixed with 2.0% glutaraldehyde in
0.1 M cacodylate buffer (pH 7.4) for 30 min, postfixed with 1.0%
osmium tetroxide for 30 min at room temperature, stained with uranyl
acetate for 30 min at room temperature, dehydrated with ethanol,
released from the surface of the tissue culture dishes with propylene
oxide as previously described (16), and embedded in Epon.
Approximately 70-nm-thick sections were stained with uranyl acetate and
lead citrate and then examined with a Hitachi H-600 transmission
electron microscope.
Confluent human fibroblast monolayers adherent to 60-mm tissue
culture-treated dishes in Iscove medium and 5% CO2-95%
air at 37°C were infected with 105 M. abscessus-R or M. abscessus-S for 2 h and then
washed three times with 37°C Iscoves medium. The monolayers were then
reincubated in 5% CO2-95% air at 37°C. After 2 days,
the monolayers were fixed as described above. In order to examine
M. abscessus secondarily invading adjacent fibroblasts after
primary infection, monolayers were embedded in situ in tissue culture
dishes with a thin layer of Epon. After removal of the embedded
monolayers, sections approximately 70-nm thick were cut parallel to the
original surface of the tissue culture dish, stained with uranyl
acetate and lead citrate, and examined with a Hitachi H-600
transmission electron microscope.
Statistics.
Data were compared by using the Student's
t test. Data were considered significant with a P
value of <0.05.
 |
RESULTS |
M. abscessus-R has a rough colony morphology compared
to M. abscessus-S, which has a smooth colony
morphology.
When grown on 7H11 agar plates, M. abscessus-R exhibits a colony texture that is rough and dry. In
contrast, M. abscessus-S exhibits a colony texture that is
smooth and moist (Fig. 1).

View larger version (90K):
[in this window]
[in a new window]
|
FIG. 1.
Morphologic appearance of M. abscessus-R
(left) and M. abscessus-S (right) colonies. These are
7-day-old colonies on 7H11 agar.
|
|
In a murine pulmonary model of infection, M. abscessus-S lacks the ability to persist within the host.
To
determine whether there are phenotypic differences between M. abscessus-R and M. abscessus-S in vivo, we infected
BALB/c mice with these variants and compared clearance, dissemination, and pathology. M. abscessus-S was cleared to undetectable
levels, and CFU were never recovered from the spleen. In contrast,
M. abscessus-R persisted in the lung at 28 days
postinfection and was disseminated to the spleen by day 14, although
CFU in both the lung and spleen began to decline at day 14 (data not
shown). Since the immune response in immunocompetent mice is a major
influence on the course of infection and inflammation, we examined the
course of infection of these variants in SCID mice which have an
immunodeficient B-cell and T-cell response (Fig.
2). We felt infection of these mice would
more clearly reflect the innate ability of these variants to persist
and elicit inflammation. From day 7 to day 28, M. abscessus-R persisted in the lung with little change in CFU over
this time period. This ability of M. abscessus to persist in
the lung was observed in all experiments. Although M. abscessus-R disseminated to the spleen in some experiments, this
was not as consistent as persistence in the lung and was not observed
in all experiments. In contrast, M. abscessus-S was rapidly
cleared from the lung despite having higher mean CFU levels in the lung
at day 7, and no organisms were found in the spleen over the 28-day
period of observation (Fig. 2).

View larger version (21K):
[in this window]
[in a new window]
|
FIG. 2.
In a murine pulmonary model of infection, M. abscessus-R persists in both the lung and spleen and disseminates
to the spleen, whereas M. abscessus-S is rapidly cleared and
does not disseminate. SCID mice (n = 4) were
intratracheally inoculated with 104 M. abscessus-R or M. abscessus-S organisms. At the
indicated time intervals, the mice were sacrificed and the total lung
and spleen CFU values were determined. The data represent the mean ± the standard deviation. *, M. abscessus-R versus
M. abscessus-S in the lung (P < 0.05);
**, M. abscessus-R versus M. abscessus-S in
the spleen (P < 0.05) (t test).
|
|
M. abscessus-S lacks the ability to persist and
multiply in human monocyte monolayers.
Human monocyte monolayers
were infected with the M. abscessus variants, and CFU were
assayed over 5 days (Fig. 3). Monocyte monolayers had similar numbers of M. abscessus-R and
M. abscessus-S organisms at time zero. M. abscessus-R CFU persisted and multiplied slowly in the monolayer,
while M. abscessus-S CFU decreased at each successive time
point such that there was approximately a 1 log difference between
M. abscessus-R and M. abscessus-S at 5 days (Fig.
3). This divergence between M. abscessus-R and M. abscessus-S was also noted when M. abscessus-infected
monocyte lysates from monolayers infected for 0, 48, and 72 h were
inoculated into BACTEC 12B culture bottles and the growth index was
determined at daily intervals. In this experiment, there was no
increase in the growth index of either M. abscessus-R or
M. abscessus-S from 0 to 48 h; however, from 48 to
72 h, the growth index of M. abscessus-R increased
310%, whereas the growth index of M. abscessus-S increased
only 3%. Monocytes remained over 95% viable over the course of all
the experiments, indicating that neither variant had a toxic effect on
monocytes independent of bacterial growth.

View larger version (14K):
[in this window]
[in a new window]
|
FIG. 3.
M. abscessus-R persists and multiplies in
human monocyte monolayers in contrast to M. abscessus-S.
Human monocyte monolayers were infected with 2.5 × 105 M. abscessus-R or M. abscessus-S
for 6 h. After being washed, cell lysates and supernatants were
plated for CFU at the indicated intervals. CFU in supernatants were
less than 5% of the CFU in lysates at all points. Data are the mean of
duplicate determinations of two separate experiments. *, M. abscessus-R versus M. abscessus-S (P < 0.002; t test).
|
|
M. abscessus-R and M. abscessus-S enter
human monocytes and reside in morphologically distinct phagosomes.
Similar numbers of the M. abscessus variants became
associated with the monocyte monolayers at time zero (Fig. 3). To
confirm the intracellular location of the variants, electron microscopy was performed on monocytes which had been incubated with either M. abscessus-R or M. abscessus-S. Electron
microscopy showed that both variants are internalized by monocytes but
reside in distinctly different phagosomes (Fig.
4).

View larger version (140K):
[in this window]
[in a new window]
|
FIG. 4.
M. abscessus variants are phagocytized by
human monocytes and reside in phagosomes with differing morphology.
Human monocyte monolayers were incubated with 106 M. abscessus-R or M. abscessus-S for 1 h, followed by
washing and an additional 30 min of incubation to allow for
internalization of bacteria. Electron microscopy was then performed.
Fifteen consecutive phagosomes were identified for each group,
containing one to four bacteria per monocyte. All bacteria were within
monocytes. (A) Three M. abscessus-R in a phagosome typical
for pathogenic mycobacteria with a tightly adherent phagosomal membrane
(arrow). (B) Three M. abscessus-S organisms in separate
"loose" phagosomes with the phagosomal membrane separated from the
bacterial cell wall (arrow). Magnification, ×12,000.
|
|
M. abscessus-S has diminished capability to spread from
cell to cell in a fibroblast-mycobacterium microcolony assay.
The
ability of M. abscessus-R and M. abscessus-S to
invade human fibroblasts was examined. Over a period of 3 to 5 days,
these variants formed microcolonies in the fibroblast monolayers which were visible to the naked eye and had distinctive microscopic features
(Fig. 5). After acid-fast staining, the
mean microcolony diameter and standard deviation of 50 consecutive
microcolonies from each variant was determined. M. abscessus-R microcolonies had a mean diameter of 0.77 ± 0.15 mm compared to M. abscessus-S microcolonies, which had a
mean diameter of 0.17 ± 0.12 mm (P < 0.01; t
test).

View larger version (140K):
[in this window]
[in a new window]
|
FIG. 5.
M. abscessus variants form distinctive
microcolonies in the fibroblast-mycobacterium microcolony assay. The
microscopic appearance of 2-day-old, unfixed, unstained M. abscessus growing in human fibroblast monolayers which had been
overlaid with agar-tissue culture medium can be seen. (A) M. abscessus-R. (B) M. abscessus-S. Magnification,
×200.
|
|
To confirm the intracellular location of these variants, electron
microscopy was performed. Both M. abscessus-R and M. abscessus-S were taken up by fibroblasts and resided in phagosomes
morphologically similar to those seen in infected monocytes. Over a
2-day period, M. abscessus-R multiplied extensively within
infected fibroblasts and secondarily invaded adjacent fibroblasts (Fig.
6). In contrast, no secondary invasion of
fibroblasts by M. abscessus-S could be identified.

View larger version (103K):
[in this window]
[in a new window]
|
FIG. 6.
M. abscessus-R multiplies extensively within
human fibroblasts and secondarily invades cells after primary
infection. (A) Numerous M. abscessus-R in fibroblast 2 days
after infection. Magnification, ×4,900. (B) M. abscessus-R
cord effacing and secondarily invading fibroblast. Magnification,
×7,700. (C) M. abscessus-R effacing and penetrating the
surface of a fibroblast. Magnification, ×4,900. (D) M. abscessus-R cord that has been internalized by a fibroblast with
bacteria becoming tightly associated with phagosomal membrane (arrow).
Magnification, ×9,800. No secondary invasion of fibroblasts by
M. abscessus-S was identified.
|
|
M. abscessus-S lacks the ability to induce the
formation of cellular aggregates in the murine pulmonary infection
model and in the human monocyte infection model.
In our murine
pulmonary infection model with SCID mice, M. abscessus-R
induced a local inflammatory response identified as discrete
collections of macrophages in the lung (Fig.
7), whereas M. abscessus-S
produced no detectable inflammation. Furthermore, the persistence and
multiplication of M. abscessus-R in human monocyte
monolayers was associated with the development of monocyte aggregates
(Fig. 8A). Staining for acid-fast bacilli
showed M. abscessus-R to be present in these aggregates
(data not shown). In contrast, no cellular aggregates were observed in
monocyte monolayers infected with M. abscessus-S (Fig. 8B).

View larger version (102K):
[in this window]
[in a new window]
|
FIG. 7.
The lungs of SCID mice infected with M. abscessus-R contain numerous inflammatory foci which are absent in
the lungs of M. abscessus-S-infected mice. (A) Seven days
after infection with M. abscessus-R. Arrows indicate
prominent perivascular inflammatory infiltrates. The arrowhead points
to a small number of peribronchiolar inflammatory cells. The tissue was
stained with hematoxylin and eosin and photographed at ×25. (B)
Enlargement of perivascular inflammatory infiltrate seen in panel A. Magnification, ×100.
|
|

View larger version (82K):
[in this window]
[in a new window]
|
FIG. 8.
M. abscessus-R infection of human monocytes
is associated with the development of monocyte aggregates. Human
monocyte monolayers were infected with the M. abscessus
variants as in Fig. 3. After 3 days, supernatants were removed and the
monolayers were examined by trypan blue exclusion. (A) Monolayers
infected with M. abscessus-R form dense cellular aggregates.
(B) Cellular aggregates are completely lacking with M. abscessus-S. Magnification (both panels), ×100.
|
|
 |
DISCUSSION |
We have obtained an M. abscessus human clinical isolate
(M. abscessus-R) and a spontaneously occurring mutant
derived from that isolate (M. abscessus-S). Our initial
studies indicated that M. abscessus-R is able to persist and
multiply in our murine pulmonary infection model, whereas M. abscessus-S lacks this ability. Using human tissue culture models
of infection, we next sought to identify phenotypic differences between
these variants which might lead to a further understanding of virulence
mechanisms common to pathogenic mycobacteria. Validating the use of
these models is our finding that M. abscessus-S is also
deficient in its ability to persist and multiply in both human
monocytes and fibroblasts. We have identified three phenotypic
differences between these variants which may play a role in the ability
of M. abscessus-R to persist and multiply in our murine
pulmonary infection model.
The first phenotypic difference, with our human monocyte infection
model, shows that the M. abscessus phagosome differs between the two variants. The M. abscessus-R phagosome has an
appearance typical of that observed for pathogenic mycobacteria,
including M. tuberculosis (21). The bacterium is
surrounded by a tightly adherent phagosomal membrane. The
ultrastructure of the bacterial cell wall within the host membrane
consists of an outer layer, an electron-transparent layer, and an
electron-dense layer, as is also seen in pathogenic mycobacteria. In
contrast, M. abscessus-S resides in a "loose" phagosome
and lacks the typical morphological appearance of the mycobacterial
cell wall (8). We speculate on the basis of these findings,
that intracellular trafficking of these variants may be different. It
has been reported that pathogenic mycobacteria inhibit
phagosome-lysosome fusion, thereby avoiding the inhospitable lysosomal
environment (1, 2, 12, 14, 23). The difference in
persistence between these two variants could in part be due to an
inability of M. abscessus-S to prevent fusion of its
phagosome with lysosomes after entry into host cells. Another
explanation could relate to the sensitivity to toxic monocyte metabolites. For example, reactive oxygen intermediates are felt to
play a role in bacteriostasis of M. avium in a murine model (27). M. abscessus-R might be inherently
resistant on the basis of an altered cell wall structure, or it might
be residing in an intracellular compartment where it would not be
exposed to these metabolites. These possibilities are currently under investigation.
The second phenotypic difference pertains to the pattern of growth in
our fibroblast-mycobacterium microcolony assay. In the fibroblast-mycobacterium microcolony assay, M. abscessus-R
forms microcolonies with an elongated appearance which grow
intracellularly in a linear fashion along the long axes of infected
fibroblasts and which exhibit extensive cording. With this assay, these
characteristics have been shown to differentiate virulent from
avirulent M. tuberculosis (10). On electron
microscopy, M. abscessus-R cords can be seen to secondarily
invade fibroblasts. In contrast, M. abscessus-S forms
rounded, noncorded microcolonies which are significantly smaller than
M. abscessus-R microcolonies. By this assay, these characteristics have been described for the avirulent M. tuberculosis strain H37Ra (10). Cording has been
postulated to be a virulence factor for various mycobacteria.
Middlebrook, as early as 1945, demonstrated that virulent strains of
M. tuberculosis grow on the surface of liquid media as ropes
and coils, whereas avirulent strains appear smooth or wrinkled without
a cord-like appearance (19). Two recent studies from this
laboratory suggest that cord formation may play a role in the
cell-to-cell spread of virulent M. tuberculosis (10,
11). The directional movement associated with cord formation may
facilitate rapid spread of virulent mycobacteria after host cell death
by focusing bacterial growth in one direction. This would allow greater
movement by the growing mass of bacteria than would occur in bacteria
growing without cord formation. Small distances between cells could be
rapidly traversed, with the leading tip of the mycobacterial cord
invading new cells and outpacing the cellular immune response, which
would be focused on the initially infected, dead, and dying cells.
Given the striking similarity between M. abscessus-R and
virulent M. tuberculosis microcolonies on the one hand and
M. abscessus-S and avirulent M. tuberculosis H37Ra microcolonies on the other in the fibroblast-mycobacterium microcolony assay (10), it is possible that cord formation
plays an important role in virulence in both of these mycobacterial species.
The third phenotypic difference is the finding that in both human
monocyte monolayers and SCID mouse lung, infection with M. abscessus-R is associated with the development of
monocyte-macrophage aggregates, which are not observed with M. abscessus-S infection. In both of these assay conditions, there is
a deficiency of T lymphocytes, indicating that M. abscessus-R is influencing monocytes directly. Such interaction
could be the result of differing cytokine profiles released by
mononuclear phagocytes in response to each of these variants.
Monocyte-macrophage aggregation may play a role in the pathogenesis of
mycobacterial infection. It has been postulated that formation of
monocyte aggregates induced by tumor necrosis factor alpha (TNF
)
facilitates the cell-to-cell spread of M. tuberculosis cords
(9). Furthermore, it has been proposed that, although
TNF-
is necessary for granuloma formation (17), for
M. tuberculosis growth restriction to occur the cytokines gamma interferon with interleukin-3 or granulocyte-macrophage colony-stimulating factor are also required to organize the granuloma in such a way that bacterial containment occurs (11). This
explanation reconciles the paradox of TNF-
promoting granuloma
formation yet at the same time promoting cell-to-cell spread of
M. tuberculosis. In a similar fashion, formation of monocyte
aggregates in response to M. abscessus-R could be involved
in the pathogenesis of infection with this microorganism.
A common factor which may underlie these three phenotypic differences
is the bacterial cell wall. Cord factor (trehalose-6,6'-dimycolate) is
present in the cell wall of many mycobacterial species. The role of
cord factor in mycobacterial cord formation has been controversial; however, a recent report suggests that cord factor is responsible for
the cording phenomenon. In order for cording to occur,
trehalose-6,6'-dimycolate molecules must align in a specific
orientation (3). Improperly aligned
trehalose-6,6'-dimycolate molecules could account for the lack of cord
formation observed in avirulent mycobacterial species which contain
cord factor. In addition to the studies pertaining to cord factor,
there is a substantial body of work which explores the relationship
between colony morphology and virulence, as well as the basis for
variations in colony morphology within different mycobacterial species
(5, 6, 7, 20, 28). Of particular relevance to our study are
studies involving Mycobacterium kansasii. In one of these
studies examining the surface components of rough and smooth colony
variants of M. kansasii (5), it was observed that
the colony morphologies were stable, i.e., smooth colonies were not
observed among the rough variants and vice versa. Chemical analysis
showed that the rough variants were lacking in lipooligosaccharides.
Importantly, the investigators were able to relate this work to an
earlier study on the pathogenicity of these M. kansasii
strains in mice (13), leading to the conclusion that
pathogenic strains had a rough phenotype. This finding is consistent
with our observations for M. abscessus-R and M. abscessus-S. In a similar vein, significant progress has been made
in revealing the biochemistry and genetic basis for colony morphology
in M. avium. However, the relevance of these studies to our
study is unclear since M. avium glycopeptidolipids in the
bacterial cell wall are specific to this species and the association
between morphology and virulence in M. avium has not been
well defined (4). Mycobacterial cell wall components have
been associated with inflammation and induction of cytokines such as
TNF-
; however, with the exception of phenolic glycolipid I of
M. leprae, which scavenges toxic oxygen radicals generated
by activated mononuclear phagocytes (22), there is no data
which directly demonstrate a mechanism by which cell wall components of
any mycobacterial species play a role in the pathogenesis of infection
caused by that species. Using our M. abscessus variants and
our infection models, future studies will attempt to identify the
genetic basis for the persistence phenotype and correlate this with
pathogenic mechanisms involved in mycobacterial persistence.
 |
ACKNOWLEDGMENTS |
We thank Blaine Beaman for kindly providing the M. abscessus variants, Patricia Conville for assistance in the
characterization of the variants, and Gary Cage for HPLC analysis of
the variants. We are grateful to Jeff Quinn and Donna Kusewitt for
expert technical assistance with experiments and to Jan Pfeiffer for
expert technical assistance with electron microscopy.
This work was supported by the VA Medical Center, Albuquerque, N.M.,
and by National Institutes of Health grants AI35249 to T.F.B. and
HL55776 to C.R.L. C.R.L. is a Culpeper Medical Scholar, and this
work was supported in part by the Culpeper Medical Scholar Foundation.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Medicine (111J), Albuquerque Veterans Affairs Medical Center, 1501 San Pedro, SE, Albuquerque, NM 87108. Phone: (505) 265-1711, extension 2488. Fax: (505) 256-2803. E-mail: tfbyrd{at}pol.net.
Editor:
S. H. E. Kaufmann
 |
REFERENCES |
| 1.
|
Armstrong, J. A., and P. D. A. Hart.
1975.
Phagosome-lysosome interactions in cultured macrophages infected with virulent tubercle bacilli.
J. Exp. Med.
142:1-16[Abstract/Free Full Text].
|
| 2.
|
Barker, L. P.,
K. M. George,
S. Falkow, and P. L. Small.
1997.
Differential trafficking of live and dead Mycobacterium marinum organisms in macrophages.
Infect. Immun.
65:1497-1504[Abstract].
|
| 2a.
| Beaman, B. Personal communication.
|
| 3.
|
Behling, C. A.,
B. Bennett,
K. Takayama, and R. L. Hunter.
1993.
Development of a trehalose 6,6'-dimycolate model which explains cord formation by Mycobacterium tuberculosis.
Infect. Immun.
61:2296-2303[Abstract/Free Full Text].
|
| 4.
|
Belisle, J. T.,
M. R. McNeil,
D. Chatterjee,
J. M. Inamine, and P. J. Brennan.
1993.
Expression of the core lipopeptide of the glycopeptidolipid surface antigens in rough mutants of Mycobacterium avium.
J. Biol. Chem.
268:10510-10516[Abstract/Free Full Text].
|
| 5.
|
Belisle, J. T., and P. J. Brennan.
1989.
Chemical basis of rough and smooth variation in mycobacteria.
J. Bacteriol.
171:3465-3470[Abstract/Free Full Text].
|
| 6.
|
Belisle, J. T.,
L. Pascopella,
J. M. Inamine,
P. J. Brennan, and W. R. Jacobs.
1991.
Isolation and expression of a gene cluster responsible for the biosynthesis of the glycopeptidolipid antigens of Mycobacterium avium.
J. Bacteriol.
173:6991-6997[Abstract/Free Full Text].
|
| 7.
|
Belisle, J. T.,
K. Klaczkiewicz,
P. J. Brennan,
W. R. Jacobs, Jr., and J. M. Inamine.
1993.
Rough morphological variants of Mycobacterium avium. Characterization of genomic deletions resulting in the loss of glycopeptidolipid expression.
J. Biol. Chem.
268:10517-10523[Abstract/Free Full Text].
|
| 8.
|
Brennan, P. J., and P. Draper.
1994.
Ultrastructure of Mycobacterium tuberculosis, p. 274-277.
In
B. R. Bloom (ed.), Tuberculosis: pathogenesis, protection, and control. ASM Press, Washington, D.C.
|
| 9.
|
Byrd, T. F.
1997.
TNF promotes growth of virulent M. tuberculosis in human monocytes: Iron-mediated growth suppression is correlated with decreased release of TNF from iron-treated, infected monocytes.
J. Clin. Investig.
99:2518-2529[Medline].
|
| 10.
|
Byrd, T. F.,
G. M. Green,
S. E. Fowlston, and C. R. Lyons.
1998.
Differential growth characteristics and streptomycin susceptibility of virulent and avirulent Mycobacterium tuberculosis in a novel fibroblast-mycobacterium microcolony assay.
Infect. Immun.
66:5132-5139[Abstract/Free Full Text].
|
| 11.
|
Byrd, T. F.
1998.
Multinucleated giant cell formation induced by IFN /IL-3 is associated with restriction of virulent Mycobacterium tuberculosis cell to cell invasion in human monocyte monolayers.
Cell. Immunol.
188:89-96[Medline].
|
| 11a.
| Cage, G. Personal communication.
|
| 12.
|
Clemens, D. L., and M. A. Horwitz.
1995.
Characterization of the Mycobacterium tuberculosis phagosome and evidence that phagosomal maturation is inhibited.
J. Exp. Med.
181:257-270[Abstract/Free Full Text].
|
| 13.
|
Collins, F. M., and D. S. Cunningham.
1981.
Systemic Mycobacterium kansasii infection and regulation of the alloantigenic response.
Infect. Immun.
22:614-624.
|
| 13a.
| Conville, P. Personal communication.
|
| 14.
|
Frehel, C.,
C. de Chastellier,
T. Lang, and N. Rastogi.
1986.
Evidence for inhibition of lysosomal and prelysosomal compartments with phagosomes in macrophages infected with pathogenic Mycobacterium avium.
Infect. Immun.
52:252-262[Abstract/Free Full Text].
|
| 15.
|
Griffith, D. E.,
W. Girard, and R. J. Wallace.
1993.
Clinical features of pulmonary disease caused by rapidly growing mycobacteria. An analysis of 154 patients.
Am. Rev. Respir. Dis.
147:1271-1278[Medline].
|
| 16.
|
Griffiths, G.,
G. Warren,
T. Quinn,
O. Mathieu-Costello, and H. Hoppeler.
1984.
Density of newly synthesized plasma membrane proteins in intracellular membranes. I. Stereological studies.
J. Cell Biol.
98:2133-2141[Abstract/Free Full Text].
|
| 17.
|
Kindler, V.,
A. Sappino,
G. E. Grau, and P. Piguet.
1989.
The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection.
Cell
56:731-740[Medline].
|
| 18.
|
Meylan, P. R. A.,
D. D. Richman, and R. S. Kornbluth.
1992.
Reduced intracellular growth of mycobacteria in human macrophages cultivated at physiologic oxygen pressure.
Am. Rev. Respir. Dis.
145:947-953[Medline].
|
| 19.
|
Middlebrook, G.
1945.
Pathogenic components of tubercle bacilli.
Am. Rev. Tuberc.
51:244-259.
|
| 20.
|
Mills, J. A.,
M. R. McNeil,
J. T. Belisle,
W. R. Jacobs, and P. J. Brennan.
1994.
Loci of Mycobacterium avium ser2 gene cluster and their functions.
J. Bacteriol.
176:4803-4808[Abstract/Free Full Text].
|
| 21.
|
Moreira, A. L.,
J. Wang,
L. Tsenova-Berkova,
W. Hellmann,
V. H. Freedman, and G. Kaplan.
1997.
Sequestration of Mycobacterium tuberculosis in tight vacuoles in vivo in lung macrophages of mice infected by the respiratory route.
Infect. Immun.
65:305-308[Abstract].
|
| 22.
|
Neill, M., and S. J. Klebanoff.
1988.
The effect of phenolic glycolipid-1 from Mycobacterium leprae on antimicrobial activity of human macrophages.
J. Exp. Med.
167:30-42[Abstract/Free Full Text].
|
| 23.
|
Oh, Y. K., and R. M. Straubinger.
1996.
Intracellular fate of Mycobacterium avium: use of dual label spectrofluorometry to investigate the influence of bacterial viability and opsonization on phagosomal pH and phagosome-lysosome interaction.
Infect. Immun.
64:319-325[Abstract].
|
| 24.
|
Pagan-Ramos, E.,
J. Song,
M. McFalone,
M. H. Mudd, and V. Deretic.
1998.
Oxidative stress response and characterization of the oxyR-ahpC and furA-katG loci in Mycobacterium marinum.
J. Bacteriol.
180:4856-4864[Abstract/Free Full Text].
|
| 25.
|
Prince, D. S., et al.
1989.
Infection with Mycobacterium avium complex in patients without predisposing conditions.
New Engl. J. Med.
321:863-868[Abstract].
|
| 26.
|
Ramakrishnan, L.,
R. H. Valdivia,
J. H. McKerrow, and S. Falkow.
1997.
Mycobacterium marinum causes both long-term subclinical infection and acute disease in the leopard frog (Rana pipiens).
Infect. Immun.
65:767-773[Abstract].
|
| 27.
|
Sarmento, A., and R. Appelberg.
1996.
Involvement of reactive oxygen intermediates in tumor necrosis factor alpha-dependent bacteriostasis of Mycobacterium avium.
Infect. Immun.
64:3224-3230[Abstract].
|
| 28.
|
Schaefer, W. B.,
C. L. Davis, and M. L. Cohn.
1970.
Pathogenicity of transparent, opaque, and rough variants of Mycobacterium avium in chickens and mice.
Am. Rev. Respir. Dis.
102:499-506[Medline].
|
| 29.
|
Shinnick, T. M., and R. C. Good.
1994.
Mycobacterial taxonomy.
Eur. J. Clin. Microbiol. Infect. Dis.
13:884-901[Medline].
|
| 30.
|
Sommers, H. M., and R. C. Good.
1985.
Mycobacterium, p. 225.
In
E. H. Lennette (ed.), Manual of clinical microbiology, 4th ed. ASM Press, Washington, D.C.
|
| 31.
|
Wright, P. W., and R. J. Wallace.
1995.
Syndromes, diagnosis and treatment of rapidly growing mycobacteria, p. 373-389.
In
M. D. Rossman, and R. R. MacGregor (ed.), Tuberculosis: clinical management and new challenges. McGraw Hill, Inc., New York, N.Y.
|
Infection and Immunity, September 1999, p. 4700-4707, Vol. 67, No. 9
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Sampaio, E. P., Elloumi, H. Z., Zelazny, A., Ding, L., Paulson, M. L., Sher, A., Bafica, A. L., Shea, Y. R., Holland, S. M.
(2008). Mycobacterium abscessus and M. avium Trigger Toll-Like Receptor 2 and Distinct Cytokine Response in Human Cells. Am. J. Respir. Cell Mol. Bio.
39: 431-439
[Abstract]
[Full Text]
-
Arora, K., Whiteford, D. C., Lau-Bonilla, D., Davitt, C. M., Dahl, J. L.
(2008). Inactivation of lsr2 Results in a Hypermotile Phenotype in Mycobacterium smegmatis. J. Bacteriol.
190: 4291-4300
[Abstract]
[Full Text]
-
Greendyke, R., Byrd, T. F.
(2008). Differential Antibiotic Susceptibility of Mycobacterium abscessus Variants in Biofilms and Macrophages Compared to That of Planktonic Bacteria. Antimicrob. Agents Chemother.
52: 2019-2026
[Abstract]
[Full Text]
-
Ordway, D., Henao-Tamayo, M., Smith, E., Shanley, C., Harton, M., Troudt, J., Bai, X., Basaraba, R. J., Orme, I. M., Chan, E. D.
(2008). Animal model of Mycobacterium abscessus lung infection. J. Leukoc. Biol.
83: 1502-1511
[Abstract]
[Full Text]
-
Rottman, M., Catherinot, E., Hochedez, P., Emile, J.-F., Casanova, J.-L., Gaillard, J.-L., Soudais, C.
(2007). Importance of T Cells, Gamma Interferon, and Tumor Necrosis Factor in Immune Control of the Rapid Grower Mycobacterium abscessus in C57BL/6 Mice. Infect. Immun.
75: 5898-5907
[Abstract]
[Full Text]
-
Kim, H.-Y., Yun, Y.-J., Park, C. G., Lee, D. H., Cho, Y. K., Park, B. J., Joo, S.-I., Kim, E.-C., Hur, Y. J., Kim, B.-J., Kook, Y.-H.
(2007). Outbreak of Mycobacterium massiliense Infection Associated with Intramuscular Injections. J. Clin. Microbiol.
45: 3127-3130
[Abstract]
[Full Text]
-
Catherinot, E., Clarissou, J., Etienne, G., Ripoll, F., Emile, J.-F., Daffe, M., Perronne, C., Soudais, C., Gaillard, J.-L., Rottman, M.
(2007). Hypervirulence of a Rough Variant of the Mycobacterium abscessus Type Strain. Infect. Immun.
75: 1055-1058
[Abstract]
[Full Text]
-
Howard, S. T., Rhoades, E., Recht, J., Pang, X., Alsup, A., Kolter, R., Lyons, C. R., Byrd, T. F.
(2006). Spontaneous reversion of Mycobacterium abscessus from a smooth to a rough morphotype is associated with reduced expression of glycopeptidolipid and reacquisition of an invasive phenotype. Microbiology
152: 1581-1590
[Abstract]
[Full Text]
-
Howard, S. T., Byrd, T. F., Lyons, C. R.
(2002). A polymorphic region in Mycobacterium abscessus contains a novel insertion sequence element. Microbiology
148: 2987-2996
[Abstract]
[Full Text]